Thiazolo[5,4-d]pyrimidin-5(4H)-one, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-7-[[(3-fluoro-2-pyridinyl)methyl]amino]- manufacturers
|
| | Thiazolo[5,4-d]pyrimidin-5(4H)-one, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-7-[[(3-fluoro-2-pyridinyl)methyl]amino]- Basic information |
| | Thiazolo[5,4-d]pyrimidin-5(4H)-one, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-7-[[(3-fluoro-2-pyridinyl)methyl]amino]- Chemical Properties |
| density | 1.56±0.1 g/cm3(Predicted) | | form | Solid | | pka | 9.50±0.40(Predicted) | | color | White to off-white |
| | Thiazolo[5,4-d]pyrimidin-5(4H)-one, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-7-[[(3-fluoro-2-pyridinyl)methyl]amino]- Usage And Synthesis |
| Uses | Ferroportin-IN-1 is a ferroportin inhibitor extracted from patent WO2020123850A1 compound 23. Ferroportin-IN-1 can be used for the research of diseases caused by a lack of hepcidin or iron metabolism disorders[1]. | | References | [1] Li Z, et, al. Ferroportin inhibitors and methods of use. WO2020123850A1. |
| | Thiazolo[5,4-d]pyrimidin-5(4H)-one, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-7-[[(3-fluoro-2-pyridinyl)methyl]amino]- Preparation Products And Raw materials |
|